pretickt

Is BF.B a good stock to buy?

Brown-Forman Corporation · end-of-day data as of Nov 13, 2026

Brown-Forman
BF.B · $14.21B
$30.65+2.0%
Nov 13, 2026 · close
$26$28$30SepOctNov9:3016:003 months +13.9%Nov 13 · close
▲ 4
  • FCF yield+6.5%
  • MAs4 of 4
  • MACD0.03
  • Sector▲ +6.0%
Neutral
  • Earnings in20d
  • P/E20.0x
  • RSI60
  • Support-2.4%
  • Resistance+1.7%
  • Off 52w high-4.0%
  • Volume0.8x
  • Bollingerupper half
  • News0.00
  • P/E vs sector-9.7%
  • ConsensusHold · 19
  • Trendsideways
  • 52w range$23–$32
  • ATR+3.0%
  • Off ATH-63.2%
  • InsidersNone in 90d
▼ 1
  • P/E vs own+18.1%

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Brown-Forman a good stock to buy?

Brown-Forman is strong on 1 of the 5 questions about the business; weak on demand and execution. The price is about usual: 20.0 times its earnings, near its 3-year median of 18.9 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand shrinking
  2. Advantage some edge
  3. Economics profits steady
  4. Execution misses
  5. Fragility sturdy
  6. Price about usual
DemandDo people want more of what it sells?shrinking

BF.B sales growth revenue growth

-2%a year, for the last 3 years

Brown-Forman's sales fell 2% a year for 3 years, to $3.93B in fiscal 2026.

BF.B analysts' forecast revenue estimates

0%the sales they expect next fiscal year, on the last

Analysts expect Brown-Forman's sales to grow 0% to $3.94B in fiscal 2027 (17 analysts).

BF.B peers

pretickt analysis-1%its sales in 12 months, on a year before

Brown-Forman's sales fell 1% in the 12 months to Jul 31, 2026; McCormick's grew 13%, Clorox's grew 6%, J. M. Smucker's grew 5% and Hormel Foods' grew 1%.

BF.B sales by business revenue by segment

74%of its sales from Whiskey

Whiskey brought Brown-Forman 74% of its sales in fiscal 2026; Ready-to-Drink 14%.

Advantage moatIs it hard to copy?some edge

BF.B margin on each sale gross margin

61%left after making the product

Brown-Forman kept 61% of each sale after making the product in the 12 months to Jul 31, 2026; its peers' median is 39%.

EconomicsDoes it make good money?profits steady

BF.B cash generated free cash flow

$925Mcash left after investing, last 12 months

Brown-Forman generated $925M of free cash flow in the 12 months to Jul 31, 2026, more than its reported profit.

BF.B profit per share

-18%in its last fiscal year

Brown-Forman's earnings per share fell 18% in fiscal 2026, to $1.51.

ExecutionDoes it deliver what it promises?misses

BF.B earnings vs estimates

2 of 6quarters above the analysts' estimate

Brown-Forman beat the analysts' profit estimate in 2 of 6 quarters, the latest on Mar 4, 2026; 2 quarters are left out: 1 with one-time gains or charges, 1 the sources disagree on.

BF.B insider selling

-$1.47Msold, net, by its executives in 12 months

Brown-Forman's executives and directors sold a net $1.47M of shares in the 12 months to Nov 13, 2026; none bought.

BF.B number of employees

-2%fewer people in a year

Brown-Forman had 4,900 employees at the end of fiscal 2026, 2% fewer than a year before.

BF.B CEO pay

$25.3Mfor fiscal 2026, 52% of it in stock and options

Brown-Forman paid its CEO $25.3M for fiscal 2026, 52% of it in stock and options.

Fragility risksCould something break it?sturdy

BF.B financial health Altman Z-score

4.4Altman Z-score, safe above 3

Brown-Forman's Altman Z-score is 4.4 (Nov 13, 2026), above 3, where the safe zone starts.

BF.B quality checks Piotroski score

7 of 9checks passed

Brown-Forman passes 7 of the 9 Piotroski checks in the 12 months to Jul 31, 2026; it misses on return on assets and long-term debt.

BF.B biggest customers

10%of sales from its biggest customer

One customer, unnamed in Brown-Forman's 10-K, made 10% of its sales in fiscal 2026.

BF.B in past recessions

pretickt analysis-4%its sales in the worst one

Brown-Forman's sales fell in 1 of the last 2 US recessions, by as much as 4% in fiscal 2009.

Price valuationIs the price reasonable?about usual

BF.B price vs profit P/E ratio

20.0×a year's earnings

Brown-Forman's P/E ratio is 20.0 (Nov 13, 2026), near its 3-year median of 18.9.

BF.B price vs peers

pretickt analysis20.0×a year's earnings, against its peers

Investors pay 20.0 times Brown-Forman's earnings (Nov 13, 2026), more than for Clorox (19.7) and McCormick (8.5), less than for J. M. Smucker (62.0) and Hormel Foods (35.1).

BF.B growth priced in fair value

pretickt analysis+3%a year, for ten years, to be worth the price

At $30.65 a share, Brown-Forman's free cash flow must grow about 3% a year for ten years to be worth the price (Nov 13, 2026).

What is Brown-Forman's P/E ratio?

Brown-Forman's P/E ratio is 20.0 (Nov 13, 2026), near its 3-year median of 18.9. Investors pay 20.0 times Brown-Forman's earnings (Nov 13, 2026), more than for Clorox (19.7) and McCormick (8.5), less than for J. M. Smucker (62.0) and Hormel Foods (35.1).

Are insiders selling Brown-Forman stock?

Brown-Forman's executives and directors sold a net $1.47M of shares in the 12 months to Nov 13, 2026; none bought.

How does Brown-Forman make money?

Whiskey brought Brown-Forman 74% of its sales in fiscal 2026; Ready-to-Drink 14%.

How many employees does Brown-Forman have?

Brown-Forman had 4,900 employees at the end of fiscal 2026, 2% fewer than a year before.

Who are Brown-Forman's biggest customers?

One customer, unnamed in Brown-Forman's 10-K, made 10% of its sales in fiscal 2026.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.